InsiderClue
← All stocks

Xenon Pharmaceuticals Inc.

XENE Mostly scheduled
CIK 0001582313 #1255 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$22.97M
$3.26M on a plan · $19.07M straight out of an exercise
Sold at will
$640.55K
1 of 27 sales
Net
−$22.97M
−$640.55K against sales at will

By person

11 insiders · 29 transactions
1.5×

Ian Mortimer holds only 1.5 times base salary in stock. $1.21M of shares against $786.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Ian Mortimer last reported holding, valued at $60.98, the price Common Shares was last bought or sold at on the open market here, on 28 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
MORTIMER IAN
PRESIDENT & CEO
—
$21.30M (18) scheduled
−$21.30M
19,923
0.0206%
$1.21M
−36.4%
KENNEY CHRISTOPHER JOHN
Chief Medical Officer
—
$670.26K (4) scheduled
−$670.26K
2
<0.0001%
$121.95
+100.0%
GANNON STEVEN
Director
—
$640.55K (1)
−$640.55K
1,870
0.0019%
$114.03K
−6.5%
DiFabio Andrea
Chief Legal Officer
—
$230.81K (2) scheduled
−$230.81K
7,301
0.0075%
$445.19K
—
PATOU GARY
Director
—
$70.25K (1) scheduled
−$70.25K
24,896
0.0257%
$1.52M
+5.6%
Cannon Gillian
Director
—
$63.24K (1) scheduled
−$63.24K
1,455
0.0015%
$88.72K
—
Svoronos Dawn
Director
—
—
—
31,373
0.0324%
$1.91M
+25.5%
Machado Patrick
Director
—
—
—
2,645
0.0027%
$161.28K
—
Gover Justin D.
Director
—
—
—
2,645
0.0027%
$161.28K
—
GAROFALO ELIZABETH A.
Director
—
—
—
2,645
0.0027%
$161.28K
—
AULIN SHERRY
Chief Financial Officer
—
—
—
0
0.0000%
$0.00
—

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 28
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 12
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 419,991
History held since 27 Sep 2016